Brief: Renovorx Initiates Patient Enrollment At University Of Texas Southwestern Medical Center For Pivotal Phase Iii Tiger-Pac Clinical Trial
01/06/2023 13:48
June 1 (Reuters) - RenovoRx Inc RNXT.O :
* RENOVORX INITIATES PATIENT ENROLLMENT AT UNIVERSITY OF
TEXAS
SOUTHWESTERN MEDICAL CENTER FOR PIVOTAL PHASE III TIGER-PAC
CLINICAL TRIAL
* RENOVORX INITIATES PATIENT ENROLLMENT AT UNIVERSITY OF
TEXAS
SOUTHWESTERN MEDICAL CENTER FOR PIVOTAL PHASE III TIGER-PAC
CLINICAL TRIAL
Source text for Eikon: ID:nBw9zsNXWa
Further company coverage: RNXT.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on RenovoRx
See all newsBrief: Renovorx Advances Tamp Into Borderline Resectable Pancreatic Cancer With First Patient Enrolled In Investigator-Initiated Prism-Tamp Trial
RenovoRx Inc reports results for the quarter ended June 30 - Earnings Summary
Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlook
Brief: RenovoRx Q2 Net Income USD -2.911 Million
Brief: Renovorx Achieves Major Milestone With Full Enrollment In Phase Iii Tiger-Pac Trial For Locally Advanced Pancreatic Cancer